Market Closed -
Other stock markets
|
After market 04:39:32 pm | |||
149.3 USD | -0.43% | 149.4 | +0.06% |
10:47pm | Johnson & Johnson Says Erleada Combination Therapy Achieves 100% BCR-Free Rate | MT |
03:59pm | J&J: to present advances in retinal diseases | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 361B | |
+26.08% | 681B | |
+21.85% | 556B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B | |
+8.08% | 149B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson : Germany, Netherlands, Italy to Resume Rollout of Johnson & Johnson's COVID-19 Jab